Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
> Pharma China Web Edition
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
21 Bridge Street
Metuchen, NJ 08840, USA
Tel/Fax:
+1 801-751-5728
info@pharmachinaonline.com
Affiliated Companies
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
BJ Jicai PharmTech
Oriental Kenzo Plaza
Beijing, China
Tel:
+86 10 84476010
info@pharmachinaonline.com
Product/R&D News
2/25/2021
Harbour BioMed Announces Chinese IND Approval of for Combo Therapy of ...
2/25/2021
China Approves Two More Domestic COVID-19 Vaccines
(Free)
2/25/2021
AstraZeneca Gains Default Chinese IND Approval for Its Class 1 New Bio...
2/24/2021
Gannex Receives U.S. IND Approval for THR-β Agonist ASC41 for NASH
2/18/2021
Junshi Bio Announces sNDA Acceptance for Toripalimab Combined with Ch...
2/17/2021
BeiGene Announces U.S. FDA Acceptance of sNDA for BRUKINSA (Zanubrutin...
2/9/2021
NDA for Amarin's VASCEPA (icosapent ethyl) Accepted in China
2/9/2021
Lee's Pharma Announces Breakthrough Therapy Designation of Sorrento's ...
2/8/2021
BMS Granted Priority Review for NDA of Luspatercept in China
2/8/2021
Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
(Free)
2/3/2021
Amgen/Celgene's NDA for Apremilast Accepted in China
2/3/2021
Bayer's NDA for Finerenone Accepted in China
2/1/2021
Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of...
1/29/2021
Ascentage Granted Orphan Drug Designation to Bcl-2 Inhibitor APG-2575 ...
1/28/2021
Bio-Thera Files Biologics License Application Avastin Biosimilar with ...
1/28/2021
Longyao Pharma Granted Chinese Approval for Clinical Trial of CD20-tar...
(Free)
1/26/2021
Antengene Granted Chinese IND Approval for ATG-010 (Selinexor) in Co...
1/26/2021
EUSA and BeiGene Announce Acceptance of a Biologics License Applicati...
1/22/2021
GSK Granted Priority Review for NDA of Two-in-One HIV Drug Juluca in C...
1/22/2021
AZ and MSD's Granted Priority Review for New Indication of Lynparza (O...
1/22/2021
Everest Medicines Granted Clinical Trial Approval of Sacituzumab Govi...
1/21/2021
Jemincare Initiates Phase I Trial of Anti-SARS-Cov-2 Neutralizing Anti...
1/19/2021
TRACON Granted Priority Review Acceptance of Envafolimab NDA in Chin...
1/18/2021
Kyowa Kirin Granted Conditional Approval of Crysvita (burosumab) in Ch...
1/15/2021
Innovent's sNDA for Sintilimab as Second-line Therapy for Squamous NSC...
1/13/2021
Gracell Approved to Begin Phase 1/2 Trial of CAR-T GC007g for Leukem...
1/13/2021
Sesen Bio and Qilu Pharma Announce Acceptance IND for Vicineum in C...
1/8/2021
Everest Medicines Announces CTA Approval for P3 Trial of Sacituzumab G...
1/8/2021
VISEN Pharma Granted IND Approval for P2 Trial of Achondroplasia Drug...
1/5/2021
Chipscreen's Chiauranib Granted Breakthrough Therapy Designation in Ch...
Page:
1
/
7
Total number of articles:
201
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit